CN103505670A - Traditional Chinese medicine composition for treating primary bronchus lung cancer - Google Patents
Traditional Chinese medicine composition for treating primary bronchus lung cancer Download PDFInfo
- Publication number
- CN103505670A CN103505670A CN201310336820.3A CN201310336820A CN103505670A CN 103505670 A CN103505670 A CN 103505670A CN 201310336820 A CN201310336820 A CN 201310336820A CN 103505670 A CN103505670 A CN 103505670A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- chinese medicine
- rhizoma
- eliminating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine composition for treating primary bronchus lung cancer. The composition comprises the following traditional Chinese medicines: adenophora tetraphylla, radix glehniae, Radix Trichosanthis, concha meretricis seu cyclinae, Ophiopogon japonicus, blackend swallowwort root, Polyporus, radix asparagi, radix salviae miltiorrhizae, Rhizoma sparganii, curcuma zedoary, Ligusticum wallichii, Herba Hedyotis diffusae, Bletilla striata, edible tulip, pericarpium trichosanthis, coix seed, Pyrola calliantha, scorpion, Sculellaria barbata, centipede, honeysuckle, chrysanthemum, frankincense, myrrh, semen lepidii, lily, Stemona and solanum dulcamara. The composition provided by the invention uses immunotherapy as a main means, can induce LKA cell activity, increase macrophage NK generation, and has effects of subsiding swelling, removing stasis, eliminating disease, eliminating retention, relieving dizziness and spasm, counteracting toxic substances, removing stasis, comprehensively reliving disease, toxic, subsiding swelling, breaking crux, benefiting water-dampness, relieving phlegm coagulation, eliminating cancer, strengthening body resistance, eliminating evil and resisting cancer.
Description
Technical field:
The present invention relates to traditional Chinese medical science patent medicine, especially a kind of Chinese medicine composition for the treatment of primary bronchogenic carcinoma of lung.
Background technology:
Primary bronchogenic carcinoma of lung (being called for short Lung Cancer Ca) means the cancerous protuberance that is primary in bronchial mucosa and alveolar.In a lot of developed countries, pulmonary carcinoma accounts for first place in male's kinds of tumor, and women accounts for second , China male and accounts for the 4th, and women accounts for the 5th, also has and increases year by year trend.The common condition of illness of pulmonary carcinoma is cough, hemoptysis and bloody sputum, heating, chest pain, out of breath etc.Take cough, hemoptysis and bloody sputum as onset symptoms.How the General Symptoms of pulmonary carcinoma occurs late, and common malaise is become thin, anemia, and bone closes loose, strong toe, gynecomastia, the herpes zoster etc. of referring to of pestle.If can there is hoarseness, Head And Face and edema of the upper extremity, the enlargement of supraclavicular fossa lymph in oncothlipsis or infringement adjacent tissue, often occur that liver, brain bone shift late period, because primary disease is once finding symptom, entered middle and advanced stage, integrative therapy there is no specially good effect and definite therapy.
Summary of the invention:
For those postoperative recurrences, excision is recurred again again, with recurrence and the problems such as prevention that shift, for those, can not be treated surgically, the medium and advanced lung cancer patient of interventional therapy or chemicotherapy, and the recovery of postoperative body constitution, the problems such as treatment of toxicity after chemicotherapy, doctor trained in Western medicine is felt simply helpless, and at this moment dialectical the treating of Chinese medicine has great advantage.Therefore the present invention adopts following Chinese prescription compatibility: Radix Adenophorae, Radix Glehniae, Radix Trichosanthis, Concha Meretricis seu Cyclinae, Radix Ophiopogonis, Radix Cynanchi Atrati, Polyporus, Radix Asparagi, Radix Salviae Miltiorrhizae, Rhizoma Sparganii, Rhizoma Curcumae, Rhizoma Chuanxiong, Herba Hedyotidis Diffusae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Pseudobulbus Cremastrae Seu Pleiones, Pericarpium Trichosanthis, Semen Coicis, Herba Pyrolae, Scorpio, Herba Scutellariae Barbatae, Scolopendra, Flos Lonicerae, Flos Chrysanthemi, Olibanum, Myrrha, Semen Lepidii (Semen Descurainiae), Bulbus Lilii, the Radix Stemonae, Herba Solani Lyrati totally two ten eight taste Chinese medicines by specific embodiment preparation method be prepared into watered pill (hereinafter to be referred as, Chinese kmedicine bolus agent of the present invention) for the every 5g that takes of patients with lung cancer, day three times, warm water is sent down, plus-minus: use Radix Codonopsis 15g for deficiency of vital energy person, Radix Astragali 15g decocts juice and takes Chinese kmedicine bolus agent of the present invention, for spitting of blood Herba Agrimoniae 20g, Herba Ecliptae 10g, Rhizoma Imperatae 30g decocts juice and takes watered pill.For heating person, use Gypsum Fibrosum, fresh Rhizoma Phragmitis is decocted juice and is taken watered pill.For Radix Salviae Miltiorrhizae 15g, Radix Astragali 9g, Radix Notoginseng powder (silkworm) 3g for chest pain severe patient, decoct juice and take Chinese kmedicine bolus agent of the present invention.
Herba Hedyotidis Diffusae, Herba Solani Lyrati, Flos Lonicerae heat-clearing and toxic substances removing in top, the anticancer cancer that presses down, modern pharmacology confirms that it still has adjustment immunologic function.Radix Adenophorae, Radix Glehniae, Radix Trichosanthis, Radix Ophiopogonis, Radix Asparagi nourishing lung-YIN, improve body resistance against diseases.Improve body's immunity and carry out anti-curing oncoma.The present invention be take immunization therapy as Main Means, and Herba Pyrolae, the contained polysaccharide of Polyporus can be induced LKA cytoactive, and can make macrophage NK generate increases, Pseudobulbus Cremastrae Seu Pleiones dispersing swelling and dissipating binds, dispersing tumor eliminate indigestion.Scolopendra, the Scorpio spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain, the power that it walks to alter is best, interior and internal organs outer and meridians.All QI and blood cohesion parts all can be opened it.Property have micro-poison, and turn kind removing toxic substances, all poison of all skin infection all can disappear it.Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Olibanum, Myrrha blood circulation promoting and blood stasis dispelling, to help the merit of eliminating stagnation, it is depressed to fall apart that Rhizoma Sparganii, Rhizoma Curcumae enter edema caused by disorder of QI, and Pericarpium Trichosanthis, the Radix Stemonae be take and changed the loose expectorant of diseases caused by retention of fluid and coagulate as work.Full side plays the swollen , Po Disorder knot of Herba Sidae Szechuensis altogether, and diuretic is wet, the solidifying cancerous protuberance that disappears of reducing phlegm, strengthening vital QI to eliminate pathogenic factors, the merit of anticancer dispersing tumor.
The specific embodiment:
Below in conjunction with specific embodiment, the invention will be further described:
Get Radix Adenophorae 20g, Radix Glehniae 20g, Radix Trichosanthis 20g, Concha Meretricis seu Cyclinae 20g, Radix Ophiopogonis 15g, Radix Cynanchi Atrati 15g, Polyporus 20g, Radix Asparagi 15g, Radix Salviae Miltiorrhizae 15g, Rhizoma Sparganii 15g, Rhizoma Curcumae 25g, Rhizoma Chuanxiong 15g, Herba Hedyotidis Diffusae 15g, Pseudobulbus Bletillae (Rhizoma Bletillae) 15g, Pseudobulbus Cremastrae Seu Pleiones 15g, Pericarpium Trichosanthis 15g, Semen Coicis 3g, Herba Pyrolae 3g, Scorpio 15g, Herba Scutellariae Barbatae 30g, 3 of Scolopendras, Flos Lonicerae 10g, Flos Chrysanthemi 10g, Flos Lonicerae 10g, Olibanum 10g, Myrrha 10g, Semen Lepidii (Semen Descurainiae) 30g, Bulbus Lilii 15g, Radix Stemonae 15g, Herba Solani Lyrati 30g is totally two ten nine taste prescription compatibilities.
The preparation method of Chinese kmedicine bolus agent of the present invention:
1, Polyporus, the Pseudobulbus Bletillae (Rhizoma Bletillae), Pseudobulbus Cremastrae Seu Pleiones, Pericarpium Trichosanthis, Scorpio, Scolopendra, Flos Lonicerae seven taste Chinese medicines pulverize powdered after drying or drying.
2, Radix Adenophorae, Radix Glehniae, Radix Trichosanthis, Concha Meretricis seu Cyclinae, Radix Ophiopogonis, Radix Cynanchi Atrati, Radix Asparagi, Radix Salviae Miltiorrhizae, Rhizoma Sparganii, Rhizoma Curcumae, Rhizoma Chuanxiong, Herba Hedyotidis Diffusae, Semen Coicis, Herba Pyrolae, Herba Scutellariae Barbatae, Flos Chrysanthemi, Olibanum, Myrrha, Semen Lepidii (Semen Descurainiae), Bulbus Lilii, the Radix Stemonae, Herba Solani Lyrati enter altogether pot with decocting in water, endure 2 hours.After leaching medicine juice and above-mentioned medicamental pulverata stir, dry or dry.Respectively add for the second time, for the third time decocting in water and endure 1 hour, leaching medicine juice and medicated powder dry or dry after stirring respectively.
3, the further porphyrize of medicated powder stirring after drying or drying through 3 medicine juice is crossed to 120 mesh sieve water general for ball is as large in Semen phaseoli radiati, drying or drying is a kind of Chinese kmedicine bolus agent for the treatment of primary bronchogenic carcinoma of preparation cost invention.
Every 5g that takes that is grown up, oral 3 times, warm water is sent down, and children's's oldaged physically weak person cut down according to the circumstance.
The present embodiment is applicable to the treatment of phase morning, noon and afternoon patients with lung cancer.
The present invention takes clinical observation by 105 routine patients with lung cancer, and wherein 45 routine combinations are treated, radiotherapy or operative treatment, and alleviator's 25 examples of coughing after taking medicine, after treatment, all low grade fever declines, and only steals juice, dry pharynx, dry mouth improves.Later continual cure, 1 year above survival rate 40%, wherein 3 examples reach more than 9 years life cycles.
Model case:
Chen, female, 61 years old, peasant, obtained advanced lung cancer.Certain CT of hospital of process and MRI are checked through the dagger-axe small stream clinic treatment recovery from illness now of in January, 2012 to the February Qingtian county, Zhejiang province Chuan Liao of Shanghai tumour hospital of Fudan University town and work again normal.
Leaf so-and-so, female, 43 years old, peasant, obtained advanced lung cancer.Through certain general physical checkup CT of hospital and MRI, check Shanghai Fu Qie tumour hospital, last March is normal to the multiple work of Chuan Liao town, Qingtian county, Zhejiang province dagger-axe small stream clinic treatment recovery from illness now.
Liu so-and-so, female, 56 years old, peasant, obtained middle and late stage pulmonary carcinoma, through certain MRI, checked and CT examination, in April, 2008 is normal to the multiple work of Chuan Liao town, Qingtian county, Zhejiang province dagger-axe small stream clinic treatment recovery from illness now.Not recurrence in 5 years, recovery from illness.
Claims (1)
1. a Chinese medicine composition for the treatment of primary bronchogenic carcinoma of lung, the weight that it is characterized in that prescription compatibility and each Chinese medicine: Radix Adenophorae 20g, Radix Glehniae 20g, Radix Trichosanthis 20g, Concha Meretricis seu Cyclinae 20g, Radix Ophiopogonis 15g, Radix Cynanchi Atrati 15g, Polyporus 20g, Radix Asparagi 15g, Radix Salviae Miltiorrhizae 15g, Rhizoma Sparganii 15g, Rhizoma Curcumae 25g, Rhizoma Chuanxiong 15g, Herba Hedyotidis Diffusae 15g, Pseudobulbus Bletillae (Rhizoma Bletillae) 15g, Pseudobulbus Cremastrae Seu Pleiones 15g, Pericarpium Trichosanthis 10g, Semen Coicis 3g, Herba Pyrolae 3g, Scorpio 15g, Herba Scutellariae Barbatae 30g, 3 of Scolopendras, Flos Lonicerae 10g, Flos Chrysanthemi 10g, Olibanum 10g, Myrrha 10g, Semen Lepidii (Semen Descurainiae) 30g, Bulbus Lilii 15g, Radix Stemonae 15g, Herba Solani Lyrati 30g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310336820.3A CN103505670A (en) | 2013-07-30 | 2013-07-30 | Traditional Chinese medicine composition for treating primary bronchus lung cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310336820.3A CN103505670A (en) | 2013-07-30 | 2013-07-30 | Traditional Chinese medicine composition for treating primary bronchus lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103505670A true CN103505670A (en) | 2014-01-15 |
Family
ID=49889443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310336820.3A Pending CN103505670A (en) | 2013-07-30 | 2013-07-30 | Traditional Chinese medicine composition for treating primary bronchus lung cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103505670A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001127A (en) * | 2014-05-14 | 2014-08-27 | 陈洪佳 | Multiple-traditional Chinese medicine mixed drug for treating primary bronchopulmonary carcinoma |
CN104740252A (en) * | 2015-03-06 | 2015-07-01 | 姜新帅 | Chinese medicinal composition for treating lung cancer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513512A (en) * | 2003-08-21 | 2004-07-21 | 董继昌 | Nano-chinese medicine composition for treating primary bronchus lung cancer and its preparation method |
-
2013
- 2013-07-30 CN CN201310336820.3A patent/CN103505670A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1513512A (en) * | 2003-08-21 | 2004-07-21 | 董继昌 | Nano-chinese medicine composition for treating primary bronchus lung cancer and its preparation method |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001127A (en) * | 2014-05-14 | 2014-08-27 | 陈洪佳 | Multiple-traditional Chinese medicine mixed drug for treating primary bronchopulmonary carcinoma |
CN104740252A (en) * | 2015-03-06 | 2015-07-01 | 姜新帅 | Chinese medicinal composition for treating lung cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520395B (en) | Traditional Chinese medicine composition for treating lung cancer | |
CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
CN101658657B (en) | Drug for treating chronic cholecystitis | |
CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
CN104758762A (en) | Traditional Chinese medicine composition for treating tuberculosis | |
CN103505670A (en) | Traditional Chinese medicine composition for treating primary bronchus lung cancer | |
CN103893481A (en) | Traditional Chinese medicine watered pill preparation for treating intermediated or advanced-staged liver cancer | |
CN106266972A (en) | A kind of Chinese medicine formula treating pulmonary carcinoma | |
CN100542565C (en) | A kind of Chinese medicine for oral administration for the treatment of cephalagra type hemihidrosis disease | |
CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
CN104623605A (en) | Traditional Chinese medicine capable of treating breast cancer | |
CN103816436A (en) | Traditional Chinese medicine composition for treating downward flow of damp-heat | |
CN103690852A (en) | Medicine for treating phthisis and preparation method of medicine | |
CN102294012A (en) | Chinese medicinal composition for treating diarrhoea | |
CN103100013B (en) | Traditional Chinese medicine decoction for treating bronchiectasis | |
CN107596295A (en) | It is a kind of to be used to treat Chinese medicine preparation of lung cancer and preparation method thereof | |
CN105079580A (en) | Traditional Chinese medicine composition for treating wind-warm lung-heat disease | |
CN1994454A (en) | Orally administered Chinese medicine for treating viral myocarditis caused by phlegm fire disturbing heart | |
CN104352773A (en) | Traditional Chinese medicine preparation for treating chronic bronchitis and bronchial asthma | |
CN104771577A (en) | Traditional Chinese medicine composition for treating constipation | |
CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN103735955B (en) | The medicine for the treatment of pulmonary carcinoma | |
CN105288174A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
CN101095837B (en) | Decoction medicine for treating dry and hard excrement type chronic bronchitis and method for preparing the same | |
CN101095834B (en) | Decoction medicine for treating aypnia fantod type chronic bronchitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C05 | Deemed withdrawal (patent law before 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140115 |